- Home
- ENVB vs CISS Comparison
ENVB vs CISS Comparison
Compare ENVB & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- CISS
- Stock Information
- Founded
- ENVB 1994
- CISS 2022
- Country
- ENVB United States
- CISS Greece
- Employees
- ENVB N/A
- CISS N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- CISS Marine Transportation
- Sector
- ENVB Health Care
- CISS Consumer Discretionary
- Exchange
- ENVB Nasdaq
- CISS Nasdaq
- Market Cap
- ENVB 3.1M
- CISS 2.8M
- IPO Year
- ENVB N/A
- CISS N/A
- Fundamental
- Price
- ENVB $1.29
- CISS $3.57
- Analyst Decision
- ENVB Strong Buy
- CISS
- Analyst Count
- ENVB 1
- CISS 0
- Target Price
- ENVB $10.00
- CISS N/A
- AVG Volume (30 Days)
- ENVB 225.8K
- CISS 90.3K
- Earning Date
- ENVB 08-11-2025
- CISS 05-15-2025
- Dividend Yield
- ENVB N/A
- CISS N/A
- EPS Growth
- ENVB N/A
- CISS N/A
- EPS
- ENVB N/A
- CISS N/A
- Revenue
- ENVB N/A
- CISS $38,174,754.00
- Revenue This Year
- ENVB N/A
- CISS N/A
- Revenue Next Year
- ENVB N/A
- CISS N/A
- P/E Ratio
- ENVB N/A
- CISS N/A
- Revenue Growth
- ENVB N/A
- CISS N/A
- 52 Week Low
- ENVB $1.01
- CISS $2.85
- 52 Week High
- ENVB $11.55
- CISS $23.25
- Technical
- Relative Strength Index (RSI)
- ENVB 46.13
- CISS 53.78
- Support Level
- ENVB $1.18
- CISS $3.23
- Resistance Level
- ENVB $1.30
- CISS $4.13
- Average True Range (ATR)
- ENVB 0.07
- CISS 0.33
- MACD
- ENVB 0.02
- CISS 0.02
- Stochastic Oscillator
- ENVB 50.00
- CISS 56.41
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.